NZNa Zhang

Na Zhang

*This is an algorithmically generated author record based on publicly available information.

Na Zhang has a total of 116 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers
    Open Access

    Low dose IL-2 therapy restores regulatory T cells in patients with systemic lupus erythematosus in a dose-dependent manner: a phase IIb trial

    by Xia Zhang, Ruiling Feng, Yifan Wang, Wenqiang Fan, Xiao Gao, Miaomiao Ma, Guanmin Gao, Dongbin Jiang, Ting Li, Huifang Guo, et al.

    Low-dose interleukin 2 (Ld-IL2) has shown therapeutic effects in autoimmune diseases, particularly systemic lupus erythematosus (SLE), yet optimal dosage has not been established in clinical trials. In this multicentre, double-blind, phase IIb trial, 152 patients with active SLE were randomised (1:1:1:1) to receive subcutaneous IL2 (0.2, 0.5, or 1.0 million IU) or placebo every other day for 12 weeks, then weekly for another 12 weeks. At week 12, SRI-4 response rates were higher in the IL2 1 M IU (69.7%), 0.5 M IU (64.7%), and 0.2 M IU (42.9%) groups than the placebo control group (23.5%). Notably, these differences persisted until week 24 (P < 0.001). Moreover, achievement of LLDAS increased in a dose-dependent manner. Patients who received 1 M IU also showed significant reductions in PGA scores, anti-dsDNA antibody titres and prednisone dosages. Infection rates were lower in the IL2 groups compared with placebo. Ld-IL2 drove the expansion of regulatory T cells (Tregs) and altered Treg/effector T cell ratios. These findings highlight the dose-dependent efficacy of IL2 with a favourable safety profile. (Clinicaltrials.gov registration number: NCT04077684).


  • Top Cited Papers
    Open Access

    Semiquantitative HRCT scoring: a reliable predictor of rapidly progressive interstitial lung disease in patients with anti-MDA5 positive dermatomyositis

    by Chen Zhang, Fan Yang, Xinlei Liu, Caixin Wu, Qing Wang, Na Zhang, Dong Li

    Anti-melanoma differentiation-associated gene 5 positive dermatomyositis (anti-MDA5 DM) is strongly linked to rapidly progressive interstitial lung disease (RP-ILD), which is associated with high early mortality. This study aimed to explore the feasibility of using semiquantitative visual scoring methods on high-resolution computed tomography (HRCT) to assess RP-ILD in anti-MDA5 DM patients, and to develop a risk prediction model for RP-ILD, given the poor prognosis of RP-ILD in anti-MDA5 DM. The data of patients with anti-MDA5 DM were retrospectively analyzed. Seven HRCT-based semiquantitative scoring methods were used to assess the extent of interstitial lung disease (ILD), and the correlation of each method with the pulmonary function tests (PFTs) was analyzed. The diagnostic performance of each method for RP-ILD was also evaluated. A nomogram model was developed to predict RP-ILD risk. In total, 67 patients with anti-MDA5 DM were included in the study. Methods 1, 2, 4, 5, and 6 significantly distinguished RP-ILD from non-RP-ILD (P<0.05). Method 1 showed the highest correlation with the PFTs and the best diagnostic performance for RP-ILD [area under the curve (AUC) =0.766, P<0.001]. The least absolute shrinkage and selection operator logistic regression analysis identified male sex, an advanced age at onset, fever, a decreased normal extent in the left lower lung zone, an increased consolidation extent in the left middle lung zone, and elevated C-reactive protein as predictors of RP-ILD. These six predictors were used to construct a prediction model, which had an AUC of 0.842 based on internal validation, and showed good predictive ability and clinical applicability after the calibration and clinical decision curve analyses. Semiquantitative visual scoring based on HRCT can effectively assess the severity of ILD in anti-MDA5 DM patients. A predictive model for RP-ILD that incorporates imaging and clinical information has potential for clinical application.


  • Open Access

    Pulpotomy for teeth with irreversible pulpitis in immature permanent teeth: a retrospective case series study

    by Na Zhang, Qian Kang, Yuzhao Cheng

    To evaluate the success of pulpotomy in treating immature permanent teeth with irreversible pulpitis. This case series included patients with irreversible pulpitis admitted to the Department of Oral Medicine at the author’s Hospital between 2015 and 2020. The pulpotomies were carried out by clinicians with > 5 years of working experience. The follow-up findings and radiographic images were reviewed by two attending dentists. This study included 49 teeth from 48 children (25 boys and 23 girls). The follow-up was 23.3 ± 6.8 months (from 12 to 40 months). The success rate of pulpotomy was 85.7% (42/49). Pulpotomy failed in seven teeth (14.3%). The treatment success rate for traumatic crown fracture was lower than for dental caries and dens evaginatus (P < 0.001). There were no significant differences in the success rate of the pulp-capping agent, tooth root developmental phase, and pulpotomy method (all P > 0.05). Pulpotomy might be successfully used to treat immature permanent teeth with irreversible pulpitis in young patients mainly caused by caries and a fractured tubercle of dens evaginatus.


  • Open Access

    The anti-leukemia activity and mechanisms of shikonin: a mini review

    by Han Dong, Chun-Di Chang, Fei Gao, Na Zhang, Xing-Jian Yan, Xue Wu, Yue-Hui Wang

    Leukemia encompasses a group of highly heterogeneous diseases that pose a serious threat to human health. The long-term outcome of patients with leukemia still needs to be improved and new effective therapeutic strategies continue to be an unmet clinical need. Shikonin (SHK) is a naphthoquinone derivative that shows multiple biological function includes anti-tumor, anti-inflammatory, and anti-allergic effects. Numerous studies have reported the anti-leukemia activity of SHK during the last 3 decades and there are studies showing that SHK is particularly effective towards various leukemia cells compared to solid tumors. In this review, we will discuss the anti-leukemia effect of SHK and summarize the underlying mechanisms. Therefore, SHK may be a promising agent to be developed as an anti-leukemia drug.


  • Open Access

    Association of Platelet Desialylation and Circulating Follicular Helper T Cells in Patients With Thrombocytopenia

    by Yuwen Chen, Liping Luo, Yongzhi Zheng, Qiaoyun Zheng, Na Zhang, Donghui Gan, Shimuye Kalayu Yirga, Zhenxing Lin, Qizhen Shi, Lin Fu, et al.

    Thrombocytopenia is a multifactorial condition that frequently involves concomitant defects in platelet production and clearance. The physiopathology of low platelet count in thrombocytopenia remains unclear. Sialylation on platelet membrane glycoprotein and follicular helper T cells (TFHs) are thought to be the novel platelet clearance pathways. The aim of this study was to clarify the roles of platelet desialylation and circulating TFHs in patients with immune thrombocytopenia (ITP) and non-ITP thrombocytopenia. We enrolled 190 patients with ITP and 94 patients with non-ITP related thrombocytopenia including case of aplastic anemia (AA) and myelodysplastic syndromes (MDS). One hundred and ten healthy volunteers were included as controls. We found significantly increased desialylated platelets in patients with ITP or thrombocytopenia in the context of AA and MDS. Platelet desialylation was negatively correlated with platelet count. Meanwhile, the circulating TFH levels in patients with thrombocytopenia were significantly higher than those of normal controls, and were positively correlated with desialylated platelet levels. Moreover, TFHs-related chemokine CXCL13 and apoptotic platelet levels were abnormally high in ITP patients. The upregulation of pro-apoptotic proteins and the activation of the MAPK/mTOR pathway were observed in the same cohort. These findings suggested that platelet desialylation and circulating TFHs may become the potential biomarkers for evaluating the disease process associated with thrombocytopenia in patients with ITP and non-ITP.


  • Multiple brain abscesses due to Listeria monocytogenes infection in a patient with systemic lupus erythematosus: A case report and literature review

    by Na Zhang, Wenwen Sun, Lei Zhou, Ming Chen, Xiaoying Dong, Wei Wei

    Aim To review the clinical features of systemic lupus erythematosus (SLE) complicated by central nervous system (CNS) infection due to Listeria monocytogenes. Method A patient with SLE receiving high-dose glucocorticoids combined with cyclophosphamide who developed multiple brain abscesses due to Listeria infection is described. The case is compared with known cases in a literature review. Results A review of the literature showed that CNS infections are rare bacterial complications of SLE, but they can be a significant cause of mortality, especially those due to L. monocytogenes. The most significant risk factor for listerial meningitis is a prior history of receiving immunosuppressive therapy. At-risk patients should avoid unpasteurized milk and soft cheeses along with deli-style, ready-to-eat prepared meats, particularly poultry products. The case we report is the fifth SLE patient with multiple brain abscesses due to L. monocytogenes, and the first to be discharged with no sequelae. Timely and accurate identification and treatment of CNS infections and neuropsychiatric lupus are very important for favorable disease prognosis. Conclusion Repeated blood culture is helpful for early diagnosis, and empirical anti-infective treatment that covers L. monocytogenes is recommended for SLE patients with risk factors when CNS infection occurs. A comprehensive assessment might be helpful to distinguish CNS infections from neuropsychiatric SLE. For severe infection, the dosage of steroids does not need to be reduced immediately but can be gradually adjusted based on the results of a comprehensive evaluation of the disease.


  • Open Access

    Predictive model for the probability of malignancy in solitary pulmonary nodules: A meta-analysis

    by The third affiliated hospital of Qiqihar Medical University, Tian Bai, Li-Juan Wen, Na Zhang

    INPLASY2021100006 Predictive model for the probability of malignancy in solitary pulmonary nodules: A meta-analysis Keywords: SPN; predictive model. Download PDF – 2021100006 Review Status: O…

  • Open Access

    2020 Chinese expert-based consensus on the diagnosis and treatment of connective tissue disease associated pulmonary arterial hypertension

    by Jiuliang Zhao, Qiang Wang, Yongfeng Zhang, Na Zhang, Rong Zhang, Yanjie Hao, Junfeng Jia, Mengtao Li, Xiaofeng Zeng, Chinese Rheumatic Disease Data Center (Crdc)

    Pulmonary arterial hypertension (PAH) is a severe complication of connective tissue disease (CTD) and is one of the leading causes of morbidity and mortality among patients with this condition. To establish an expert-based consensus on the diagnosis and treatment of CTD-associated PAH, a multidisciplinary consensus development panel was established. The consensus panel is composed of 45 experts in rheumatology, cardiology, pulmonology, and radiology, most of whom are members of the Group of Pulmonary Vascular and Interstitial Lung Diseases (ILD) Associated with Rheumatic Diseases. The consensus development panel compiled 9 recommendations for the diagnosis and treatment of CTD-associated PAH. It covers screening, diagnosis, disease evaluation, risk assessment, the use of immunosuppressive agents, and PAH-specific therapy with a treat-to-target approach. The consensus is intended to facilitate decision-making and standardize the care of CTD-associated PAH in China.


  • Recent advances in Extracellular Vesicles and their involvements in vasculitis

    by Nan Yang, Yin Zhao, Xiuhua Wu, Na Zhang, Haoming Song, Wei Wei, Ming-Lin Liu